BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32241801)

  • 1. Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.
    Scuccimarri R; Sutton E; Fitzcharles MA
    J Rheumatol; 2020 Jun; 47(6):783-786. PubMed ID: 32241801
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
    Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 4. The COVID-19 Pandemic and Mayo Clinic Proceedings.
    Nath KA
    Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
    [No Abstract]   [Full Text] [Related]  

  • 5. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
    Harrigan JJ; Hubbard RA; Thomas S; Riello RJ; Bange E; Mamtani M; Mamtani R
    J Gen Intern Med; 2020 Sep; 35(9):2826-2828. PubMed ID: 32542496
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: Diagnosis and Early Treatment of Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jun; 382(23):e103. PubMed ID: 32492326
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of rheumatologists in the era of COVID-19?
    Marotto D; Sarzi-Puttini P
    Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
    [No Abstract]   [Full Text] [Related]  

  • 9. Diarrhoea: An Atypical Presentation of COVID-19.
    Khan S; Ahmad Z; Khan F; Asif H; Zia-Ur-Rahman A
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):40-42. PubMed ID: 32723447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Apr; 16(690):756-757. PubMed ID: 32301315
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
    Okour M; Al-Kofahi M; Austin D
    J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
    Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Apr; 16(689):704-705. PubMed ID: 32270942
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
    Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
    Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 16. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
    Alia E; Grant-Kels JM
    J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
    Mehta B; Moezinia CJ; Jannat-Khah D; Gibofsky A; Tornberg H; Pearce-Fisher D; Goodman SM; Salmon JE; Ibrahim S
    J Clin Rheumatol; 2020 Sep; 26(6):224-228. PubMed ID: 32694358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
    Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
    Medicina (B Aires); 2020; 80(3):271-274. PubMed ID: 32442941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 infection also occurs in patients taking hydroxychloroquine.
    Lahouati M; Mériglier E; Martin L; Bouchet S; Desclaux A; Bonnet F
    J Antimicrob Chemother; 2020 Jul; 75(7):2014-2015. PubMed ID: 32417904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.